Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach
- PMID: 18445697
- DOI: 10.1177/0962280207087309
Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach
Abstract
Measuring the benefit of screening mammography is difficult due to lead-time bias, length bias and over-detection. We evaluated the benefit of screening mammography in reducing breast cancer mortality using observational data from the SEER-Medicare linked database. The conceptual model divided the disease duration into two phases: preclinical (T(0)) and symptomatic (T(1)) breast cancer. Censored information for the bivariate response vector ( T(0), T(1)) was observed and used to generate a likelihood function. However, the contribution to the likelihood function for some observations could not be calculated analytically, thus, censoring boundaries for these observations were modified. Inferences about the impact of screening mammography on breast cancer mortality were made based on maximum likelihood estimates derived from this likelihood function. Hazard ratios (95% confidence intervals) of 0.54 (0.48-0.61) and 0.33 (0.26- 0.42) for single and regular users (vs. non-users), respectively, demonstrated a protective effect of screening mammography among women 69 years and older. This method reduced the impact of lead-time bias, length bias and over-detection, which biased the estimated hazard ratios derived from standard survival models in favour of screening.
Similar articles
-
Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected.Stat Med. 2009 Jul 20;28(16):2116-46. doi: 10.1002/sim.3601. Stat Med. 2009. PMID: 19424959
-
Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.Breast Cancer Res Treat. 2009 Jul;116(1):179-85. doi: 10.1007/s10549-008-0100-8. Epub 2008 Jul 12. Breast Cancer Res Treat. 2009. PMID: 18622697
-
[Mammography screening in Germany: how, when and why?].Rofo. 2006 Oct;178(10):957-69. doi: 10.1055/s-2006-926959. Rofo. 2006. PMID: 17021975 Review. German.
-
Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group.Biometrics. 1997 Mar;53(1):217-29. Biometrics. 1997. PMID: 9147591
-
Screening mammography in women 40 to 49 years of age: yes.Important Adv Oncol. 1995:231-41. Important Adv Oncol. 1995. PMID: 7672809 Review. No abstract available.
Cited by
-
Lead-Time Corrected Effect on Breast Cancer Survival in Germany by Mode of Detection.Cancers (Basel). 2024 Mar 28;16(7):1326. doi: 10.3390/cancers16071326. Cancers (Basel). 2024. PMID: 38611004 Free PMC article.
-
The paradox of MRI for breast cancer screening: high-risk and dense breasts-available evidence and current practice.Insights Imaging. 2024 Mar 27;15(1):96. doi: 10.1186/s13244-024-01653-4. Insights Imaging. 2024. PMID: 38536530 Free PMC article. Review.
-
EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.Health Technol Assess. 2022 Dec;26(49):1-184. doi: 10.3310/IJFM4802. Health Technol Assess. 2022. PMID: 36534989 Free PMC article.
-
Cancer survival among World Trade Center rescue and recovery workers: A collaborative cohort study.Am J Ind Med. 2021 Oct;64(10):815-826. doi: 10.1002/ajim.23278. Epub 2021 Jul 19. Am J Ind Med. 2021. PMID: 34288025 Free PMC article.
-
Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter?Health Serv Res. 2014 Apr;49(2):546-67. doi: 10.1111/1475-6773.12108. Epub 2013 Sep 30. Health Serv Res. 2014. PMID: 24117371 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical